These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 34840204)

  • 1. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
    Hasegawa T; Yazaki Y
    Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
    Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging and Hematologic Findings in Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) Vaccination.
    Gangi A; Mobashwera B; Ganczakowski M; Ayto R
    Radiology; 2022 Feb; 302(2):319-325. PubMed ID: 34402666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.
    Soboleva K; Shankar NK; Yadavalli M; Ferreira C; Foskett N; Putsepp K; Ferstenberg LB; Nord M; da Silva HG; Bhuyan P
    Lancet Glob Health; 2022 Jan; 10(1):e33-e34. PubMed ID: 34919849
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.
    Kim JY; Lim SY; Park S; Kwon JS; Bae S; Park JY; Cha HH; Seo MH; Lee HJ; Lee N; Kim K; Shum D; Jee Y; Kim SH
    J Infect Dis; 2022 Mar; 225(5):777-784. PubMed ID: 34850034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.
    Plüß M; Mese K; Kowallick JT; Schuster A; Tampe D; Tampe B
    Front Immunol; 2021; 12():784145. PubMed ID: 35116025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated thrombosis after COVID-19 vaccination: case series.
    Al-Ahmad M; Al Rasheed M; Altourah L; Rodriguez-Bouza T; Shalaby N
    Int J Hematol; 2022 Feb; 115(2):153-157. PubMed ID: 34993889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
    David R; Hanna P; Lee K; Ritchie A
    Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433
    [No Abstract]   [Full Text] [Related]  

  • 11. Epigastric Pain After COVID-19 Vaccination.
    Casper M; Thurner L; Holz R; Krawczyk M; Link A
    Am J Gastroenterol; 2022 Mar; 117(3):371. PubMed ID: 35020675
    [No Abstract]   [Full Text] [Related]  

  • 12. Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Gabarin N; Patterson S; Pai M; Afzaal T; Nazy I; Sheppard JI; Arnold DM; Warkentin TE
    Thromb Haemost; 2021 Dec; 121(12):1677-1680. PubMed ID: 34384129
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
    Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
    Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of two cases of minimal change disease following vaccination for COVID -19.
    Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
    Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.
    De Michele M; Iacobucci M; Chistolini A; Nicolini E; Pulcinelli F; Cerbelli B; Merenda E; Schiavo OG; Sbardella E; Berto I; Petraglia L; Caracciolo N; Chiara M; Truglia S; Toni D
    Nat Commun; 2021 Aug; 12(1):4663. PubMed ID: 34341358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Roberge G; Carrier M
    Clin Appl Thromb Hemost; 2022; 28():10760296221086283. PubMed ID: 35275495
    [No Abstract]   [Full Text] [Related]  

  • 17. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination.
    Guan CY; Tsai SH; Fan JS; Lin YK; Kao CC
    Am J Emerg Med; 2022 Jan; 51():427.e3-427.e4. PubMed ID: 34274191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
    Badoiu A; Moranne O; Coudray S; Ion IM
    J Clin Neuromuscul Dis; 2021 Dec; 23(2):115-116. PubMed ID: 34808658
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 timeline of events.
    Webster P
    Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.